Literature DB >> 19696478

Combination of captopril and allopurinol retards fructose-induced metabolic syndrome.

Carlos A Roncal1, Sirirat Reungjui, Laura Gabriela Sánchez-Lozada, Wei Mu, Yuri Y Sautin, Takahiko Nakagawa, Richard J Johnson.   

Abstract

BACKGROUND: Both ACE inhibitors and allopurinol have been shown to partially prevent metabolic syndrome induced by fructose. We tested the hypothesis that combined therapy might be more effective at blocking the metabolic syndrome induced with fructose.
METHODS: Male Sprague-Dawley rats were fed a high fructose diet with or without allopurinol, captopril, or the combination for 20 weeks. A control group received a normal diet. All groups were pair-fed to assure equivalent caloric intake.
RESULTS: Despite reduced energy intake, the fructose-fed rats developed features of metabolic syndrome including elevated blood pressure, abdominal obesity, hypertriglyceridemia, hyperuricemia and hyperinsulinemia. While both allopurinol and captopril alone tended to reduce features of the metabolic syndrome, the combined therapy was synergistic, with significant reduction in blood pressure, less accumulation of abdominal fat, an improvement in the dyslipidemia and a complete prevention of insulin resistance.
CONCLUSION: A high fructose diet can induce metabolic syndrome even in the setting of caloric restriction. Captopril and allopurinol synergistically reduce features of the metabolic syndrome, especially hypertension, insulin resistance and dyslipidemia. Combination allopurinol and ACE inhibitor therapy might provide a superior means to prevent diabetes and cardiovascular disease. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696478      PMCID: PMC2783362          DOI: 10.1159/000235731

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  46 in total

1.  Fructose-induced hyperuricemia in essential hypertension.

Authors:  E Fiaschi; B Baggio; S Favaro; A Antonello; E Camerin; S Todesco; A Borsatti
Journal:  Metabolism       Date:  1977-11       Impact factor: 8.694

2.  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Authors:  Marilda Mazzali; John Kanellis; Lin Han; Lili Feng; Yi-Yang Xia; Qiang Chen; Duk-Hee Kang; Katherine L Gordon; Susumu Watanabe; Takahiko Nakagawa; Hui Y Lan; Richard J Johnson
Journal:  Am J Physiol Renal Physiol       Date:  2002-06

3.  Uric acid stimulates endothelin-1 gene expression associated with NADPH oxidase in human aortic smooth muscle cells.

Authors:  Hung-hsing Chao; Ju-chi Liu; Jia-wei Lin; Cheng-hsien Chen; Chieh-hsi Wu; Tzu-hurng Cheng
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

4.  Uric acid decreases NO production and increases arginase activity in cultured pulmonary artery endothelial cells.

Authors:  Sergey Zharikov; Karina Krotova; Hanbo Hu; Chris Baylis; Richard J Johnson; Edward R Block; Jawaharlal Patel
Journal:  Am J Physiol Cell Physiol       Date:  2008-09-10       Impact factor: 4.249

5.  Effect of imidapril, an angiotensin-converting enzyme inhibitor, on fructose-induced insulin resistance in rats.

Authors:  Tsuneyuki Oda; Masanobu Hirata; Yoshiharu Oshida; Yan-Qing Han; Keiichi Koshinaka; Yuzo Sato
Journal:  Endocr J       Date:  2004-02       Impact factor: 2.349

6.  Increasing prevalence of the metabolic syndrome among u.s. Adults.

Authors:  Earl S Ford; Wayne H Giles; Ali H Mokdad
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

7.  Thiazide diuretics exacerbate fructose-induced metabolic syndrome.

Authors:  Sirirat Reungjui; Carlos A Roncal; Wei Mu; Titte R Srinivas; Dhavee Sirivongs; Richard J Johnson; Takahiko Nakagawa
Journal:  J Am Soc Nephrol       Date:  2007-09-12       Impact factor: 10.121

8.  Uric acid activates extracellular signal-regulated kinases and thereafter endothelin-1 expression in rat cardiac fibroblasts.

Authors:  Tzu-Hurng Cheng; Jia-Wei Lin; Hung-Hsin Chao; Yen-Ling Chen; Cheng-Hsien Chen; Paul Chan; Ju-Chi Liu
Journal:  Int J Cardiol       Date:  2008-10-21       Impact factor: 4.164

9.  Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity.

Authors:  Masato Furuhashi; Nobuyuki Ura; Hideki Takizawa; Daisuke Yoshida; Norihito Moniwa; Hideyuki Murakami; Katsuhiro Higashiura; Kazuaki Shimamoto
Journal:  J Hypertens       Date:  2004-10       Impact factor: 4.844

10.  Dose effect of captopril on renal hemodynamics and proteinuria in conscious, partially nephrectomized rats.

Authors:  M J Radin; W L Wilke; M J Fettman
Journal:  Proc Soc Exp Biol Med       Date:  1989-03
View more
  15 in total

Review 1.  Uric acid and chronic kidney disease: which is chasing which?

Authors:  Richard J Johnson; Takahiko Nakagawa; Diana Jalal; Laura Gabriela Sánchez-Lozada; Duk-Hee Kang; Eberhard Ritz
Journal:  Nephrol Dial Transplant       Date:  2013-03-29       Impact factor: 5.992

2.  Cardiovascular Risks of Probenecid Versus Allopurinol in Older Patients With Gout.

Authors:  Seoyoung C Kim; Tuhina Neogi; Eun Ha Kang; Jun Liu; Rishi J Desai; MaryAnn Zhang; Daniel H Solomon
Journal:  J Am Coll Cardiol       Date:  2018-03-06       Impact factor: 24.094

3.  Theodore E. Woodward award. The evolution of obesity: insights from the mid-Miocene.

Authors:  Richard J Johnson; Peter Andrews; Steven A Benner; William Oliver
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

Review 4.  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.

Authors:  Yuka Sato; Daniel I Feig; Austin G Stack; Duk-Hee Kang; Miguel A Lanaspa; A Ahsan Ejaz; L Gabriela Sánchez-Lozada; Masanari Kuwabara; Claudio Borghi; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2019-07-11       Impact factor: 28.314

5.  Allopurinol ameliorates high fructose diet induced hepatic steatosis in diabetic rats through modulation of lipid metabolism, inflammation, and ER stress pathway.

Authors:  In-Jin Cho; Da-Hee Oh; Jin Yoo; You-Cheol Hwang; Kyu Jeung Ahn; Ho-Yeon Chung; Soung Won Jeong; Ju-Young Moon; Sang-Ho Lee; Sung-Jig Lim; In-Kyung Jeong
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

6.  A Regenerative Antioxidant Protocol of Vitamin E and α-Lipoic Acid Ameliorates Cardiovascular and Metabolic Changes in Fructose-Fed Rats.

Authors:  Jatin Patel; Nur Azim Matnor; Abishek Iyer; Lindsay Brown
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-09       Impact factor: 2.629

7.  New and improved strategies for the treatment of gout.

Authors:  Natalie Dubchak; Gerald F Falasca
Journal:  Int J Nephrol Renovasc Dis       Date:  2010-11-24

8.  Effects of blocking of angiotensin system on the prevalence of metabolic syndrome in type 2 diabetic patients.

Authors:  Isam Hamo Mahmood; Mohammed Najim Abed; Marwan Mohammed Merkhan
Journal:  Pak J Med Sci       Date:  2013-01       Impact factor: 1.088

9.  Common variants related to serum uric acid concentrations are associated with glucose metabolism and insulin secretion in a Chinese population.

Authors:  Xue Sun; Rong Zhang; Feng Jiang; Shanshan Tang; Miao Chen; Danfeng Peng; Jing Yan; Tao Wang; Shiyun Wang; Yuqian Bao; Cheng Hu; Weiping Jia
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

10.  Comparing the effects of inorganic nitrate and allopurinol in renovascular complications of metabolic syndrome in rats: role of nitric oxide and uric acid.

Authors:  Soha S Essawy; Khaled A Abdel-Sater; Amani A Elbaz
Journal:  Arch Med Sci       Date:  2013-03-06       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.